Core Viewpoint - New Five Feng (600975.SH) aims to enhance its profitability and competitive advantage in the pig breeding and nutrition research sector through the establishment of a technology innovation base project, with a total investment of approximately 200 million yuan [1] Group 1: Project Overview - The project, named "New Five Feng Technology Innovation Base Project (Phase I)," will cover a total construction area of 20,634.65 square meters [1] - The core focus of the project is to serve as a research and development platform for the pig industry, emphasizing long-term investment in scientific research [1] Group 2: Strategic Goals - The project aims to improve breeding production efficiency, optimize feed formulas, upgrade raw material substitution solutions, and iterate on environmental protection technologies [1] - The initiative will also involve the intelligent transformation of facilities and equipment, development of deep processing of meat products, and enhancement of digital empowerment [1] Group 3: Business Impact - By implementing cost-reduction measures and advancing product research and production, the project is expected to empower the company's main business and address cyclical challenges [1] - The company intends to align with industry trends of standardization and scale development, focusing on "cost control in breeding" as a core strategy for sustainable growth [1]

Core Points - The article discusses the public bidding process for the selection of vaccine and pharmaceutical suppliers for Hunan New Wufeng Co., Ltd. for the year 2026, highlighting various amendments to the original tender documents [1][50]. Group 1: Amendments to Pricing and Specifications - The maximum price for the progestin granules/tablets was corrected from 0.09 yuan/piece to 0.9 yuan/piece, and the unit for Gorin injection was changed to mL [2][51]. - The specification for Carboprost injection was amended from 0.7 mg per 10 mL to 0.35 mg per 10 mL [3][53]. - The unit for the 12.5% high-efficiency fluoro-cyano-pyrethroid suspension was changed from L to mL [5][55]. - The maximum bid price for 4.0g of Cefotaxime sodium injection was revised from 1.8 yuan/piece to 7.2 yuan/piece [6][56]. - The maximum price for 5% bromocyanide solution was corrected from 0.05 yuan/L to 340 yuan/L [8][58]. - The maximum bid price for 0.5% Abamectin transdermal solution was set at 0.05 yuan/mL [10][60]. - The maximum price for 20% compound sulfanilamide soluble powder was changed from 115 yuan/kg to 170 yuan/kg [12][61]. - The maximum price for 10% Cefotaxime crystal injection was canceled [14][65]. - The maximum price for Aminopyrine injection was revised from 0.6 yuan/mL to 0.06 yuan/mL [13][67]. - The maximum price for 20% oxytetracycline injection was corrected from 0.76 yuan/mL to 0.076 yuan/mL [15][69]. - The maximum price for 20% florfenicol injection was changed from 0.9 yuan/mL to 0.09 yuan/mL [17][71]. - The maximum price for 10% Tilmicosin solution was revised from 80 yuan/mL to 0.08 yuan/mL [19][72]. - The maximum price for 40% dichloroisocyanuric acid and its auxiliary agent was set at 0.0315 yuan/gram [20][73]. Group 2: Technical Requirements and Evaluation Criteria - The core strains for the liquid fermentation feed bacteria must include lactic acid bacteria, bacillus, and yeast, ensuring no prohibited strains are present [21][75]. - The total viable count of probiotics must be ≥ 10 billion CFU/g, with a survival rate of ≥ 80% under specified storage conditions [23][87]. - The fermentation cycle must achieve a pH below 4.0 within 48 hours at 25-37°C, producing a strong sour aroma [25][89]. - The fermentation product should be rich in beneficial substances such as probiotics, lactic acid, small peptides, and organic acids [26][90]. - The successful fermentation must have a shelf life of ≥ 5 days under sealed conditions [27][91]. - The product must not contain pathogenic bacteria and must comply with national feed additive safety standards [29][91]. - The packaging must be airtight, light-proof, and corrosion-resistant [30][92]. - Technical services must include detailed usage plans, technical training, and effect tracking after winning the bid [31][93]. Group 3: Bidding Timeline and Submission Details - The deadline for electronic bid submissions for various sections is set for January 7, 8, and 9, 2026, respectively [44][96][98]. - The project guarantees the lowest price in Hunan Province, and bid prices will not be disclosed to protect the commercial secrets of bidders [49][100].

Core Viewpoint - New Wufeng (600975) announced the establishment of the "New Wufeng Technology Innovation Base Project (Phase I)" through its wholly-owned subsidiary Tianxin Seed Industry, focusing on agricultural research and development [1] Group 1: Project Overview - The project includes the establishment of the Hunan Tianxin Seed Industry Co., Ltd. Technology R&D Center and a Swine Industry Research Institute, which will focus on research and collaboration in the swine industry [1] - The total construction area of the project is 20,634.65 square meters [1] - The total investment for the project is 200 million yuan [1]

Group 1 - The core point of the article is that New Five Feng (SH 600975) announced the convening of its sixth board meeting to discuss the construction of a technology innovation base project [1] - For the fiscal year 2024, New Five Feng's revenue composition is as follows: livestock industry accounts for 76.4%, wholesale and retail for 22.81%, feed processing for 0.69%, and other businesses for 0.1% [1] - As of the report date, New Five Feng has a market capitalization of 7.4 billion yuan [1]

证券代码：600975 证券简称：新五丰 公告编号：2025-064 湖南新五丰股份有限公司 重要内容提示： 投资标的名称：新五丰科技创新基地项目（一期）（以下简称"科创 基地项目"） 投资金额：湖南新五丰股份有限公司（以下简称"公司"）全资子公 司湖南天心种业有限公司（以下简称"天心种业"）拟建设"新五丰科技创新 基地项目（一期）"，包含湖南天心种业有限公司科技研发中心（2023 年向特 定对象发行股份募集配套资金项目）、生猪产业研究院（专注生猪产业科研 攻关与产学研协同）。项目总建筑面积合计 20634.65 ㎡，项目总投资 19,989.21 万元。 交易实施尚需履行的审批及其他相关程序：公司第六届董事会第二十 一次会议审议通过了《关于建设新五丰科技创新基地项目（一期）的议案》。 根据《上海证券交易所股票上市规则》及《公司章程》的相关规定，本次对 外投资事项无需提交股东会审议。 其它需要提醒投资者重点关注的风险事项：科创基地项目实施前，需 完成环评审批、建设工程规划许可、施工许可等多项前置审批程序。若国家 或地方相关政策调整、项目审批等实施条件发生变化，项目可能面临顺延、 1 变更、中止或终止的风险。同 ...

证券代码：600975 证券简称：新五丰 公告编号：2025-063 湖南新五丰股份有限公司 第六届董事会第二十一次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、董事会会议召开情况 湖南新五丰股份有限公司（以下简称"公司"）第六届董事会第二十一次会 议于 2025 年 12 月 25 日（周四）以通讯方式召开。公司董事 7 名，实际参加表 决董事 7 名。会议召开程序符合《公司法》《公司章程》及其他法律法规的规定。 二、董事会会议审议情况 经统计各位董事通讯表决票，本次会议审议表决结果如下： 1、关于建设新五丰科技创新基地项目（一期）的议案 为聚焦生猪育种与营养研发，推动智能化技术升级，进一步强化综合技术 创新能力、构建差异化竞争优势，长效提升公司盈利能力，公司全资子公司湖 南天心种业有限公司拟建设"新五丰科技创新基地项目（一期）"，项目总建筑 面积合计 20634.65 ㎡，项目总投资 19,989.21 万元。 董事会授权公司管理层办 理涉及本次建设新五丰科技创新基地项目（一期）的具体事宜并签署相关文件 ...

格隆汇12月26日｜新五丰公告称，公司第六届董事会第二十一次会议审议多项议案。全资子公司湖南天 心种业拟建设"新五丰科技创新基地项目（一期）"，总建筑面积20634.65㎡，总投资19989.21万元。此 外，控股子公司扎赉特旗天和粮食拟分别向交通银行长沙湘湖支行、邮储银行扎赉特旗支行申请1000万 元新增授信，期限1年；公司拟向招商银行长沙分行申请20000万元续授信，期限2年。上述议案均以7票 同意通过。 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性依法承担法律责任。 重要内容提示： ● 本次股票上市类型为非公开发行股份；股票认购方式为网下，上市股数为232,705,626股。 本次股票上市流通总数为232,705,626股。 ● 本次股票上市流通日期为2026年1月6日。 一、本次限售股上市类型 湖南新五丰股份有限公司（以下简称"新五丰"或"公司"）本次限售股上市流通类型为发行股份及支付现 金购买资产向特定对象发行限售股。具体情况如下： （一）股票发行核准情况 2022年12月29日，公司收到中国证券监督管理委员会核发的《关于核准湖南新五丰股份有限公司向湖南 省现代农业产业控股集团有限公司等发行股份购买资产并募集配套资金的批复》（证监许可[2022]3238 号），核准公司发行股份购买相关资产，并核准公司发行股份募集配套资金不超过 17.70 亿元。 公司本次购买资产向交易对手方发行股份的具体情况如下： ■ 备注：公司发行股份及支付现金购买资产之发行对象西藏茶逸农业科技有限公司、西藏逸锦实 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：600975 证券简称：新五丰 公告编号：2025-062 湖南新五丰股份有限公司 关于发行股份及支付现金购买资产并募集配套资金暨关联交易之限售股股票上市流通公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性依法承担法律责任。 重要内容提示： ● 本次股票上市类型为非公开发行股份；股票认购方式为网下，上市股数为232,705,626股。 本次股票上市流通总数为232,705,626股。 ● 本次股票上市流通日期为2026年1月6日。 本次发行股份及支付现金购买资产发行的271,438,269股新增股份已于 2023年1月6日在中国证券登记结 算有限责任公司上海分公司办理完毕股份登记手续。 （三）锁定期安排 1、公司发行股份及支付现金购买资产之发行对象湖南省现代农业产业控股集团有限公司（以下简称"现 代农业集团"）、湖南省现代种业投资有限公司（以下简称"种业投资"）、湖南新五丰一期产业投资基 金企业（有限合伙）（以下简称"新五丰基金"）因本次重组取得的上市公司股份，自本次发行结束之 ...

招商证券股份有限公司 关于湖南新五丰股份有限公司 发行股份及支付现金购买资产并募集配套资金暨关联交易 之限售股份上市流通的核查意见 招商证券股份有限公司（以下简称"招商证券"、"独立财务顾问"）作 为湖南新五丰股份有限公司（以下简称"新五丰"、"上市公司"、"公司"） 2022 年发行股份及支付现金购买资产并募集配套资金项目（以下简称"本次重 组"、"本次交易"）的持续督导独立财务顾问，根据《上市公司重大资产重 组管理办法（2025 修正）》《上市公司并购重组财务顾问业务管理办法》《上 海证券交易所股票上市规则（2025 年 4 月修订）》和《上海证券交易所上市公 司自律监管指引第 1 号——规范运作（2025 年 5 月修订）》等相关法律法规及 规范性文件的规定，对公司本次重组部分限售股解除限售并上市流通事项进行 了审慎核查，具体情况如下： 一、本次申请解除限售股份的基本情况 （一）本次限售股上市类型 新五丰本次限售股上市流通类型为发行股份及支付现金购买资产向特定对 象发行限售股。 （二）本次限售股核准情况 中国证券监督管理委员会于 2022 年 12 月 28 日出具《关于核准湖南新五丰 股份有限公司向湖 ...